Bayer recently inaugurated a new plant at its Vapi site in Gujarat. The plant will manufacture Ethiprole, an active ingredient used in insecticides for crop protection products. Set up with an investment of € 24 million (Rs 200 crores), the plant’s annual production capacity is 1,500 metric tons. It will cater to domestic demand in India and export to global markets across Asia Pacific and Latin America.
The Vapi site is an integral part of Bayer’s commitment towards the Government’s vision of ‘Make in India’ that aims to promote job creation and build best-in-class manufacturing infrastructure, ensuring sustained growth of the Indian economy. Inaugurated in 1994, the Vapi site employs 1,200 full time employees and is Bayer’s largest global synthetic pyrethroids production facility, with nearly 80% of the production exported to USA, Brazil, France, Germany, Indonesia, Japan and Australia. Spread over 85 acres, the Vapi site manufactures 11 active ingredients and 11 intermediatesfor use in crop protection, animal health and home &garden applications.
“The agriculture sector is currently the largest end-user of Ethiprole, which is emerging as one of the best insecticides for a variety of crops. With our new insecticide plant, we will fulfill domestic needs for Indian agriculture and also export to global agricultural markets. India is one of Bayer’s key growth markets in Crop Science and with this strategic investment, we aim to further enhance our global competitiveness in agrochemical manufacturing and supply chain,” said Narendra Shah, Director, Bayer Vapi Private Limited.